Real-time enrollment status for this immune thrombocytopenia clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:57 PM UTC
| NCT Number | NCT07007962 |
| Recruiting Status | Recruiting |
| Condition | Immune Thrombocytopenia |
| Phase | PHASE3 |
| Target Enrollment | 60 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Sanofi |
| Last Updated on CT.gov | June 22, 2026 (Jun 22, 2026) |
As of October 12, 2026: Clinical trial NCT07007962 is currently recruiting participants. This phase3 study for immune thrombocytopenia is actively seeking new participants at 12 locations across the United States. The study is sponsored by Sanofi. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07007962 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07007962 was last updated Jun 22, 2026 (June 22, 2026). HelloStudys verifies this status automatically.